Anirudh Joshi
@anirrjoshi
Followers
524
Following
1K
Media
3
Statuses
130
Co-Founder and CEO @valarlabs AI+Medicine 🇺🇸
Stanford, CA
Joined February 2020
Great conversation between @VigneshPackiam and @UroCancerMD on our recent @EurUrolOncol Publication describing the clinical utility of Vesta BCGPredict especially in an era of BCG shortage and new treatments to aid with selection of intravesical treatment. @pjhensley11.
Listen to an engaging conversation hosted by @urotoday between two leaders in bladder cancer @UroCancerMD and @VigneshPackiam on our data in @EurUrolOncol using Vesta BCGPredict to analyze patient outcomes between BCG vs Gem/Doce. Interview: Big thank.
0
0
4
We'd like to thank all the collaborators involved in making this study a reality @siadaneshmand @UroCancerMD @UroDocAsh @VigneshPackiam @YairLotan @pjhensley11 @VikramNarayan @SWilliams_MD @UrogerliMD @SpiessPhilippe, John Taylor, Mike O'Donnell, @marigfern, @BrynLauner.
1
2
8
We find that CHAI biomarkers could independently prognosticate recurrence and progression outcomes in this disease state and could outperform current guideline based risk stratification. (3/5).
1
0
0
Depending on which guideline system used, patients with high grade Ta tumors can be classified into differing risk groups which can lead to different treatment choices. (2/5).
1
0
0
Excited to share our @valarlabs publication in @EUplatinum validating Vesta Risk Stratify computational histology AI biomarkers to predict recurrence and progression in High Grade Ta Bladder Cancer. (1/5). Publication:
2
8
26
Thrilled to be working together @VigneshPackiam.
Excited to share this paper which has been many years in the making!. This is the first publication of a predictive (AI-histology based) biomarker to guide rational use of BCG vs Gem/Doce for newly diagnosed HG NMIBC. Curves say it all 👇🏾
0
1
4
Grateful to collaborate with you @UroDocAsh !.
Our recent publication in @EurUrolOncol demonstrates - for the first time -that an AI-powered histologic biomarker (CHAI) can predict response to intravesical BCG vs. gemcitabine/docetaxel in high-grade NMIBC. A critical step forward in precision intravesical therapy.
0
0
2
RT @UroDocAsh: Our recent publication in @EurUrolOncol demonstrates - for the first time -that an AI-powered histologic biomarker (CHAI) ca….
0
35
0
RT @LauraBukavinaMD: Excited for our growing collaboration with @CleClinicUro and @valarlabs>> empowering our #BladderCancer patients with….
0
4
0
With a plethora of choices coming to bladder cancer management, being able to guide treatment decision making is critical for optimal patient outcomes. We are thrilled to demonstrate that Vesta, our flagship diagnostic in bladder cancer, can predict patients who would likely.
We are thrilled to share our recent publication in @EurUrolOncol demonstrating for the first time CHAI based predictive biomarker to guide use of intravesical BCG vs alternatives (chemotherapy). In an era of BCG shortage and new alternatives to BCG incoming, precision medicine
0
0
9
RT @valarlabs: We are thrilled to share our recent publication in @EurUrolOncol demonstrating for the first time CHAI based predictive biom….
0
6
0
RT @VigneshPackiam: Excited to share this paper which has been many years in the making!. This is the first publication of a predictive (AI….
0
23
0
RT @urotoday: An #ArtificialIntelligence-powered predictive biomarker for response to intravesical BCG versus gemcitabine-docetaxel for hig….
0
10
0
RT @GUOncologyNow: 📺 @AmandaNizamMD speaks with @VigneshPackiam about his innovative study on an AI-powered model designed to predict patie….
0
4
0
RT @vintweeta: Our goals: New medicines. New practice of medicine. Our team: @a16z's global venture capital platform, together with @EliLi….
statnews.com
Eli Lilly is partnering with the fabled venture capital firm Andreessen Horowitz on a new fund backed with $500 million of the drug giant’s money.
0
48
0
RT @Forbes: "At the end you need to build a self-sustaining engine." . @anirrjoshi, #ForbesUnder30 lister, spoke about the power of cold ca….
0
6
0
RT @zklaassen_md: AI Powered Model to Predict Response to Intravesical BCG Versus Gem-Doce for HR NMIBC @VigneshPackiam @valarlabs @urotoda….
0
10
0